Expression of M30 and M65 in celiac disease. Analytical cross-sectional study

Detalhes bibliográficos
Autor(a) principal: Aksoy, Evrim Kahramanoğlu
Data de Publicação: 2018
Outros Autores: Şimşek, Gülçin Güler, Torgutalp, Murat, Sapmaz, Ferdane Pirinççi, Akpınar, Muhammet Yener, Uzman, Metin, Nazlıgül, Yaşar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: https://periodicosapm.emnuvens.com.br/spmj/article/view/616
Resumo: BACKGROUND: The role of villous atrophy in apoptosis, a distinctive feature of celiac disease, is a matter of controversy. The aim of this study was to determine the apoptosis rate through immunohistochemical staining for M30 and M65 in celiac disease cases. DESIGN AND SETTING: Analytical cross-sectional study in a tertiary-level center. METHODS: Duodenal biopsies from 28 treatment-naive patients with celiac disease, 16 patients with po- tential celiac disease, 10 patients with a gluten-free diet and 8 controls were subjected to immunohisto- chemical staining for the end-apoptotic marker M30 and the total cell death marker M65. H-scores were compared. Several laboratory parameters were recorded concomitantly, and at the one-year follow-up for celiac disease and potential celiac disease patients. RESULTS: There was a significant difference in H-score for M30 expression between the celiac disease, potential celiac disease and gluten-free diet groups (P = 0.009). There was no significant difference in H-score for M65 expression. There was a positive correlation between the H-score for M30 expression and the anti-tissue transglutaminase immunoglobulin A (anti-tTgIgA) and anti-tissue transglutaminase immunoglobulin G (anti-tTgIgG) levels (R = 0.285, P = 0.036; and R = 0.307, P = 0.024, respectively); and between the H-score for M65 expression and the anti-tTgIgA and anti-tTgIgG levels (R = 0.265, P = 0.053; and R = 0.314, P = 0.021, respectively). There was no difference between celiac disease and potential celiac disease patients regarding the laboratory parameters selected. CONCLUSION: The rates of apoptosis and nutritional deficiencies in patients with potential celiac disease were similar to those in patients with celiac disease.
id APM-1_9ebf6c458f6d50c7ef3319a569417b9b
oai_identifier_str oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/616
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Expression of M30 and M65 in celiac disease. Analytical cross-sectional studyCeliac diseaseM30 cytokeratin-18 peptide, humanM65 antigen, humanBACKGROUND: The role of villous atrophy in apoptosis, a distinctive feature of celiac disease, is a matter of controversy. The aim of this study was to determine the apoptosis rate through immunohistochemical staining for M30 and M65 in celiac disease cases. DESIGN AND SETTING: Analytical cross-sectional study in a tertiary-level center. METHODS: Duodenal biopsies from 28 treatment-naive patients with celiac disease, 16 patients with po- tential celiac disease, 10 patients with a gluten-free diet and 8 controls were subjected to immunohisto- chemical staining for the end-apoptotic marker M30 and the total cell death marker M65. H-scores were compared. Several laboratory parameters were recorded concomitantly, and at the one-year follow-up for celiac disease and potential celiac disease patients. RESULTS: There was a significant difference in H-score for M30 expression between the celiac disease, potential celiac disease and gluten-free diet groups (P = 0.009). There was no significant difference in H-score for M65 expression. There was a positive correlation between the H-score for M30 expression and the anti-tissue transglutaminase immunoglobulin A (anti-tTgIgA) and anti-tissue transglutaminase immunoglobulin G (anti-tTgIgG) levels (R = 0.285, P = 0.036; and R = 0.307, P = 0.024, respectively); and between the H-score for M65 expression and the anti-tTgIgA and anti-tTgIgG levels (R = 0.265, P = 0.053; and R = 0.314, P = 0.021, respectively). There was no difference between celiac disease and potential celiac disease patients regarding the laboratory parameters selected. CONCLUSION: The rates of apoptosis and nutritional deficiencies in patients with potential celiac disease were similar to those in patients with celiac disease.São Paulo Medical JournalSão Paulo Medical Journal2018-12-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/616São Paulo Medical Journal; Vol. 136 No. 6 (2018); 525-532São Paulo Medical Journal; v. 136 n. 6 (2018); 525-5321806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/616/559https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAksoy, Evrim KahramanoğluŞimşek, Gülçin GülerTorgutalp, MuratSapmaz, Ferdane PirinççiAkpınar, Muhammet YenerUzman, MetinNazlıgül, Yaşar2023-08-31T21:42:33Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/616Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-08-31T21:42:33São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
spellingShingle Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
Aksoy, Evrim Kahramanoğlu
Celiac disease
M30 cytokeratin-18 peptide, human
M65 antigen, human
title_short Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_full Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_fullStr Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_full_unstemmed Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
title_sort Expression of M30 and M65 in celiac disease. Analytical cross-sectional study
author Aksoy, Evrim Kahramanoğlu
author_facet Aksoy, Evrim Kahramanoğlu
Şimşek, Gülçin Güler
Torgutalp, Murat
Sapmaz, Ferdane Pirinççi
Akpınar, Muhammet Yener
Uzman, Metin
Nazlıgül, Yaşar
author_role author
author2 Şimşek, Gülçin Güler
Torgutalp, Murat
Sapmaz, Ferdane Pirinççi
Akpınar, Muhammet Yener
Uzman, Metin
Nazlıgül, Yaşar
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Aksoy, Evrim Kahramanoğlu
Şimşek, Gülçin Güler
Torgutalp, Murat
Sapmaz, Ferdane Pirinççi
Akpınar, Muhammet Yener
Uzman, Metin
Nazlıgül, Yaşar
dc.subject.por.fl_str_mv Celiac disease
M30 cytokeratin-18 peptide, human
M65 antigen, human
topic Celiac disease
M30 cytokeratin-18 peptide, human
M65 antigen, human
description BACKGROUND: The role of villous atrophy in apoptosis, a distinctive feature of celiac disease, is a matter of controversy. The aim of this study was to determine the apoptosis rate through immunohistochemical staining for M30 and M65 in celiac disease cases. DESIGN AND SETTING: Analytical cross-sectional study in a tertiary-level center. METHODS: Duodenal biopsies from 28 treatment-naive patients with celiac disease, 16 patients with po- tential celiac disease, 10 patients with a gluten-free diet and 8 controls were subjected to immunohisto- chemical staining for the end-apoptotic marker M30 and the total cell death marker M65. H-scores were compared. Several laboratory parameters were recorded concomitantly, and at the one-year follow-up for celiac disease and potential celiac disease patients. RESULTS: There was a significant difference in H-score for M30 expression between the celiac disease, potential celiac disease and gluten-free diet groups (P = 0.009). There was no significant difference in H-score for M65 expression. There was a positive correlation between the H-score for M30 expression and the anti-tissue transglutaminase immunoglobulin A (anti-tTgIgA) and anti-tissue transglutaminase immunoglobulin G (anti-tTgIgG) levels (R = 0.285, P = 0.036; and R = 0.307, P = 0.024, respectively); and between the H-score for M65 expression and the anti-tTgIgA and anti-tTgIgG levels (R = 0.265, P = 0.053; and R = 0.314, P = 0.021, respectively). There was no difference between celiac disease and potential celiac disease patients regarding the laboratory parameters selected. CONCLUSION: The rates of apoptosis and nutritional deficiencies in patients with potential celiac disease were similar to those in patients with celiac disease.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-06
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/616
url https://periodicosapm.emnuvens.com.br/spmj/article/view/616
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/616/559
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
dc.source.none.fl_str_mv São Paulo Medical Journal; Vol. 136 No. 6 (2018); 525-532
São Paulo Medical Journal; v. 136 n. 6 (2018); 525-532
1806-9460
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1825135057567744000